Business Context and Reporting Period
This Form 8-K is a current report filed by Trovagene, Inc. (not Cardiff Oncology, Inc.) on March 27, 2017. The filing reports an "Other Event" under Item 8.01 regarding a scheduled corporate presentation.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report regarding a specific event and does not contain financial statements or performance data.
Material Changes
No material financial changes versus a prior comparable period are reported in this filing. The document solely announces a future corporate event.
Outlook, Management Commentary, and Risks
- Event Announcement: CEO Bill Welch will present at the MicroCap Conference on April 4, 2017, at 9:00 AM EDT at the Essex House in New York City.
- Exhibits: A press release dated March 27, 2017, is included as Exhibit 99.1.
- Risks and Contingencies: No specific risks, contingencies, or unusual items are disclosed in this filing.
Investor Verification Checklist
- Verify the company name is Trovagene, Inc., as the input metadata referenced Cardiff Oncology, Inc.
- Confirm the date and location of the CEO's presentation at the MicroCap Conference.
- Review the attached press release (Exhibit 99.1) for any additional details on the presentation topic.
- Note that this filing contains no financial data; refer to the most recent 10-Q or 10-K for financial metrics.